Dr. Somerville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Lee St
Charlottesville, VA 22908Phone+1 434-924-5219Fax+1 434-924-9720
Summary
- Dr. Lindsay Somerville is a pulmonologist in Charlottesville, VA and is affiliated with University of Virginia Medical Center. She received her medical degree from Virginia Commonwealth University School of Medicine and has been in practice 10 years. She specializes in critical care medicine, cystic fibrosis, infectious disease, and pleural disease. She has more than 10 publications and over 150 citings.
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2010 - 2013
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2013
- Virginia Commonwealth University School of MedicineClass of 2010
- University of Virginia Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine
Certifications & Licensure
- VA State Medical License 2014 - 2026
- PA State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- General Health, Attitudes, and Activity in Self-directed Exercise in Patients With Cystic Fibrosis (GAINS-CF) Start of enrollment: 2021 May 31
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.Lindsay Somerville, Larry Borish, Imre Noth, Dana Albon
Therapeutic Advances in Respiratory Disease. 2024-11-15 - 4 citationsAnalysis of iron status after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.Amber James, Galvin Li, Rhonda List, Kevin Lonabaugh, Aaron D Smith
Pediatric Pulmonology. 2024-03-01 - 1 citationsReal world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis.Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James
Pharmacotherapy. 2024-03-01
Press Mentions
- Q&A: From the Front Lines, Dr. Catherine Bonham Talks COVID-19July 14th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: